Hrt Financial LP Rocket Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

$18.1 Billion
Q3 2024

A detailed history of Hrt Financial LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 26,149 shares of RCKT stock, worth $305,420. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,149

Holding current value

$305,420

% of portfolio

0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$17.6 - $25.88 $460,222 - $676,736	26,149 New	26,149 $482,000
Q3 2023 Nov 13, 2023	BUY	$15.07 - $24.05 $484,681 - $773,496	32,162 Added 97.42%	65,176 $1.34 Million
Q2 2023 Aug 11, 2023	BUY	$16.59 - $23.6 $547,702 - $779,130	33,014 New	33,014 $655,000
Q1 2022 May 16, 2022	SELL	$13.16 - $23.68 $477,063 - $858,423	-36,251 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$21.52 - $36.02 $780,121 - $1.31 Million	36,251 New	36,251 $791,000
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $800,489 - $1.22 Million	-18,470 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $430,351 - $1.1 Million	18,470 New	18,470 $1.01 Million
Q1 2019 May 14, 2019	SELL	$13.45 - $19.01 $170,868 - $241,503	-12,704 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$11.21 - $23.53 $142,411 - $298,925	12,704 New	12,704 $188,000

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

Rtw Investments, LP New York, NY

17.7M
Shares

$207 Million
5.21% of portfolio
Wellington Management Group LLP Boston, MA

11.2M
Shares

$131 Million
0.04% of portfolio
Black Rock Inc. New York, NY

6.19M
Shares

$72.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.54M
Shares

$64.7 Million
0.0% of portfolio
Westfield Capital Management CO LP Boston, MA

4.49M
Shares

$52.5 Million
0.39% of portfolio

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $884M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account